Alzheimer’s disease, a common disease among the elderly, deserves worldwide attention. Concerns about the aging population, which is a global phenomenon, are closely related to this disease. According to a United Nations report (2006), the number of people aged 60 and up is expected to triple in forty years, totaling two (2) billion by 2050. To add to this, Alzheimer’s disease (AD) affected 500,000 people in the UK and 36.5 million worldwide. The world’s aging population, combined with an increase in Alzheimer’s cases among the senior population, justifies the undertaking of this study to investigate the possible role of prions in Alzheimer’s